Global Gabapentin Market Size, Share & Industry Trends Analysis Report By Application (Epilepsy, Restless Legs Syndrome, Neuropathic Pain), By Dosage Form (Capsule, Tablet and Oral Solution), By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
Published Date : 31-Mar-2023 | Pages: 203 | Formats: PDF |
COVID-19 Impact on the Gabapentin Market
Market Overview
The Global Gabapentin Market size is expected to reach $2.6 billion by 2028, rising at a market growth of 4.5% CAGR during the forecast period.
An anticonvulsant drug called gabapentin is primarily employed to treat neuropathic pain and partial seizures. It is a first-line treatment for central pain, postherpetic neuralgia, and neuropathic pain brought on by diabetic neuropathy. It works to some extent in patients who receive gabapentin for postherpetic neuralgia or diabetic neuropathy.
Gabapentin is a GABA analog, although it does not attach to GABAA and GABAB receptors or benzodiazepine, opioid, or cannabinoid receptors. However, it can raise GABA levels and lower glutamate levels. Some people have also hypothesized that gabapentin may lessen the production of pain-related peptides and might lessen opioid-induced hyperalgesia.
Identifying a special gabapentin-binding protein as a component of the voltage-dependent calcium channel complex points to a less specific mechanism of action via modification of neurosignaling. Gabapentin works by affecting the electrical simulations in the brain and inducing neurotransmitters, which communicate between nerve cells. The gabapentin tablets and capsules are used orally in combination with other medicines. Both adults and children can use the medication.
The right amount of gabapentin depends on the drug's brand, kind, strength, effectiveness, renal function, and other important factors (weight, age, health). The rise in the elderly population, rise in government initiatives, rise in the frequency of seizures, the convenience of purchase, investments by pharmaceutical companies in R&D, and increasing product approvals are expected to fuel market expansion.
COVID-19 Impact Analysis
Those suffering from chronic pain were disproportionately affected by the negative effects of the societal changes brought on by the COVID-19 crisis. Living with chronic pain jeopardizes a person's basic social demands for the agency, belonging, and justice. During the pandemic, ongoing or worsening chronic pain resulted from feeling more socially threatened for some people. Moreover, the restrictions on the supply chain decreased the availability of gabapentin drugs. Therefore, the pandemic had a negative impact on the gabapentin market.
Market Growth Factors
Increasing utilization of gabapentin in various conditions
Gabapentin drugs are widely used to treat epilepsy, chronic pain, and restless legs syndrome. Through years of studies, it has been established that the drug can treat various other health issues. Gabapentin is one of the initial recommendations in multiple sclerosis as it lessens spasticity. It is a well-known remedy for restless legs syndrome. Uremic pruritus, which results from kidney failure, and other types of itching are both lessened by gabapentin. In cases of orthostatic or essential tremors, gabapentin might be an alternative. As a result, the demand for drugs like gabapentin rises, which will result in the expansion of the market.
Rising investments to develop stronger healthcare infrastructure
The opportunities anticipated to support the market expansion include the growth of emerging markets in developing nations, unexplored opportunities, improved bioavailability, upcoming healthcare clinics, and strategic initiatives by manufacturers. In addition, the strengthening of the healthcare infrastructure also attempts to increase the accessibility of generic and branded medications. As a result, the demand for drugs like gabapentin rises, which will result in the expansion of the market.
Market Restraining Factors
Increasing off label use is facilitating the occurrence of side effects
Gabapentin is primarily prescribed for the treatment of neuropathic pain and focal seizures. But in recent years, the medication has been prescribed for issues other than the intended. In the US and the UK, gabapentin is frequently administered off-label for conditions like anxiety disorders, non-neuropathic pain, and bipolar disorder. However, due to the absence of convincing scientific data supporting gabapentin's efficacy in treating various diseases and its established negative effects, there is worry regarding its off-label use. Therefore, the absence of health reimbursement schemes, rising costs, and rigorous regulatory rules are anticipated to impede market expansion.
Dosage Form Outlook
Based on dosage form, the gabapentin market is categorized into tablet, capsule, and oral solution. The tablet segment procured a considerable growth rate in the gabapentin market in 2021. Since tablets are readily available and have a high consumption rate, the tablet segment is anticipated to grow throughout the forecast period. Major products like Neurontin and Horizant are available in tablet forms. The most common are 300 mg, 600 mg, and 800 mg dosages of tablets. In addition, the segment's key trend includes a growing demand for extended-release (ER) tablets, which improve patient compliance.
Application Outlook
Based on application, the gabapentin market is segmented into epilepsy, neuropathic pain, restless legs syndrome, and others. The epilepsy segment witnessed the maximum revenue share in the gabapentin market in 2021. The dominance is associated with a worldwide rise in the incidence of active epilepsy, which necessitates ongoing pharmaceutical assistance for seizure control. In addition, more than 80% of the world's 50 million epilepsy patients reside in the middle- and lower-income nations where access to basic drugs is limited. These factors are anticipated to accelerate gabapentin's uptake.
Distribution Channel Outlook
On the basis of distribution channel, the gabapentin market is fragmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment procured the highest revenue share in the gabapentin market in 2021. The segment has a competitive advantage due to the convenience of the pharmaceutical availability and reimbursement options at these pharmacies. Also, because these pharmacies have easy access to patients' medical records, the drug prescribed is more accurate. Furthermore, these pharmacies are intended to lower total spending by encouraging generic medications.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 1.9 Billion |
| Market size forecast in 2028 | USD 2.6 Billion |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 4.5% from 2022 to 2028 |
| Number of Pages | 203 |
| Number of Table | 360 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Application, Dosage Form, Distribution Channel, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Regional Outlook
Region wise, the gabapentin market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region recorded the largest revenue share in the gabapentin market in 2021. The high incidence of neurological diseases and ailments characterized by persistent discomfort in the region is attributable to the dominance. The FDA favors generic drug launches in the region, which will increase product availability. Its highest market share is partly due to numerous manufacturers, substantial healthcare spending, and benevolent reimbursement rules.
Free Valuable Insights: Global Gabapentin Market size to reach USD 2.6 Billion by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Aurobindo Pharma Limited, Amneal Pharmaceuticals, Inc., Cipla Limited, and Apotex, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Epilepsy
- Restless Legs Syndrome
- Neuropathic Pain
- Others
By Dosage Form
- Capsule
- Tablet
- Oral Solution
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Zydus Lifesciences Ltd.
- Glenmark Pharmaceuticals Limited
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Aurobindo Pharma Limited
- Amneal Pharmaceuticals, Inc.
- Cipla Limited
- Apotex, Inc.
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gabapentin Market, by Application
1.4.2 Global Gabapentin Market, by Dosage Form
1.4.3 Global Gabapentin Market, by Distribution Channel
1.4.4 Global Gabapentin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Gabapentin Market by Application
3.1 Global Epilepsy Market by Region
3.2 Global Restless Legs Syndrome Market by Region
3.3 Global Neuropathic Pain Market by Region
3.4 Global Others Market by Region
Chapter 4. Global Gabapentin Market by Dosage Form
4.1 Global Capsule Market by Region
4.2 Global Tablet Market by Region
4.3 Global Oral Solution Market by Region
Chapter 5. Global Gabapentin Market by Distribution Channel
5.1 Global Hospital Pharmacy Market by Region
5.2 Global Retail Pharmacy Market by Region
5.3 Global Online Pharmacy Market by Region
Chapter 6. Global Gabapentin Market by Region
6.1 North America Gabapentin Market
6.1.1 North America Gabapentin Market by Application
6.1.1.1 North America Epilepsy Market by Country
6.1.1.2 North America Restless Legs Syndrome Market by Country
6.1.1.3 North America Neuropathic Pain Market by Country
6.1.1.4 North America Others Market by Country
6.1.2 North America Gabapentin Market by Dosage Form
6.1.2.1 North America Capsule Market by Country
6.1.2.2 North America Tablet Market by Country
6.1.2.3 North America Oral Solution Market by Country
6.1.3 North America Gabapentin Market by Distribution Channel
6.1.3.1 North America Hospital Pharmacy Market by Country
6.1.3.2 North America Retail Pharmacy Market by Country
6.1.3.3 North America Online Pharmacy Market by Country
6.1.4 North America Gabapentin Market by Country
6.1.4.1 US Gabapentin Market
6.1.4.1.1 US Gabapentin Market by Application
6.1.4.1.2 US Gabapentin Market by Dosage Form
6.1.4.1.3 US Gabapentin Market by Distribution Channel
6.1.4.2 Canada Gabapentin Market
6.1.4.2.1 Canada Gabapentin Market by Application
6.1.4.2.2 Canada Gabapentin Market by Dosage Form
6.1.4.2.3 Canada Gabapentin Market by Distribution Channel
6.1.4.3 Mexico Gabapentin Market
6.1.4.3.1 Mexico Gabapentin Market by Application
6.1.4.3.2 Mexico Gabapentin Market by Dosage Form
6.1.4.3.3 Mexico Gabapentin Market by Distribution Channel
6.1.4.4 Rest of North America Gabapentin Market
6.1.4.4.1 Rest of North America Gabapentin Market by Application
6.1.4.4.2 Rest of North America Gabapentin Market by Dosage Form
6.1.4.4.3 Rest of North America Gabapentin Market by Distribution Channel
6.2 Europe Gabapentin Market
6.2.1 Europe Gabapentin Market by Application
6.2.1.1 Europe Epilepsy Market by Country
6.2.1.2 Europe Restless Legs Syndrome Market by Country
6.2.1.3 Europe Neuropathic Pain Market by Country
6.2.1.4 Europe Others Market by Country
6.2.2 Europe Gabapentin Market by Dosage Form
6.2.2.1 Europe Capsule Market by Country
6.2.2.2 Europe Tablet Market by Country
6.2.2.3 Europe Oral Solution Market by Country
6.2.3 Europe Gabapentin Market by Distribution Channel
6.2.3.1 Europe Hospital Pharmacy Market by Country
6.2.3.2 Europe Retail Pharmacy Market by Country
6.2.3.3 Europe Online Pharmacy Market by Country
6.2.4 Europe Gabapentin Market by Country
6.2.4.1 Germany Gabapentin Market
6.2.4.1.1 Germany Gabapentin Market by Application
6.2.4.1.2 Germany Gabapentin Market by Dosage Form
6.2.4.1.3 Germany Gabapentin Market by Distribution Channel
6.2.4.2 UK Gabapentin Market
6.2.4.2.1 UK Gabapentin Market by Application
6.2.4.2.2 UK Gabapentin Market by Dosage Form
6.2.4.2.3 UK Gabapentin Market by Distribution Channel
6.2.4.3 France Gabapentin Market
6.2.4.3.1 France Gabapentin Market by Application
6.2.4.3.2 France Gabapentin Market by Dosage Form
6.2.4.3.3 France Gabapentin Market by Distribution Channel
6.2.4.4 Russia Gabapentin Market
6.2.4.4.1 Russia Gabapentin Market by Application
6.2.4.4.2 Russia Gabapentin Market by Dosage Form
6.2.4.4.3 Russia Gabapentin Market by Distribution Channel
6.2.4.5 Spain Gabapentin Market
6.2.4.5.1 Spain Gabapentin Market by Application
6.2.4.5.2 Spain Gabapentin Market by Dosage Form
6.2.4.5.3 Spain Gabapentin Market by Distribution Channel
6.2.4.6 Italy Gabapentin Market
6.2.4.6.1 Italy Gabapentin Market by Application
6.2.4.6.2 Italy Gabapentin Market by Dosage Form
6.2.4.6.3 Italy Gabapentin Market by Distribution Channel
6.2.4.7 Rest of Europe Gabapentin Market
6.2.4.7.1 Rest of Europe Gabapentin Market by Application
6.2.4.7.2 Rest of Europe Gabapentin Market by Dosage Form
6.2.4.7.3 Rest of Europe Gabapentin Market by Distribution Channel
6.3 Asia Pacific Gabapentin Market
6.3.1 Asia Pacific Gabapentin Market by Application
6.3.1.1 Asia Pacific Epilepsy Market by Country
6.3.1.2 Asia Pacific Restless Legs Syndrome Market by Country
6.3.1.3 Asia Pacific Neuropathic Pain Market by Country
6.3.1.4 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Gabapentin Market by Dosage Form
6.3.2.1 Asia Pacific Capsule Market by Country
6.3.2.2 Asia Pacific Tablet Market by Country
6.3.2.3 Asia Pacific Oral Solution Market by Country
6.3.3 Asia Pacific Gabapentin Market by Distribution Channel
6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
6.3.3.3 Asia Pacific Online Pharmacy Market by Country
6.3.4 Asia Pacific Gabapentin Market by Country
6.3.4.1 China Gabapentin Market
6.3.4.1.1 China Gabapentin Market by Application
6.3.4.1.2 China Gabapentin Market by Dosage Form
6.3.4.1.3 China Gabapentin Market by Distribution Channel
6.3.4.2 Japan Gabapentin Market
6.3.4.2.1 Japan Gabapentin Market by Application
6.3.4.2.2 Japan Gabapentin Market by Dosage Form
6.3.4.2.3 Japan Gabapentin Market by Distribution Channel
6.3.4.3 India Gabapentin Market
6.3.4.3.1 India Gabapentin Market by Application
6.3.4.3.2 India Gabapentin Market by Dosage Form
6.3.4.3.3 India Gabapentin Market by Distribution Channel
6.3.4.4 South Korea Gabapentin Market
6.3.4.4.1 South Korea Gabapentin Market by Application
6.3.4.4.2 South Korea Gabapentin Market by Dosage Form
6.3.4.4.3 South Korea Gabapentin Market by Distribution Channel
6.3.4.5 Singapore Gabapentin Market
6.3.4.5.1 Singapore Gabapentin Market by Application
6.3.4.5.2 Singapore Gabapentin Market by Dosage Form
6.3.4.5.3 Singapore Gabapentin Market by Distribution Channel
6.3.4.6 Malaysia Gabapentin Market
6.3.4.6.1 Malaysia Gabapentin Market by Application
6.3.4.6.2 Malaysia Gabapentin Market by Dosage Form
6.3.4.6.3 Malaysia Gabapentin Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Gabapentin Market
6.3.4.7.1 Rest of Asia Pacific Gabapentin Market by Application
6.3.4.7.2 Rest of Asia Pacific Gabapentin Market by Dosage Form
6.3.4.7.3 Rest of Asia Pacific Gabapentin Market by Distribution Channel
6.4 LAMEA Gabapentin Market
6.4.1 LAMEA Gabapentin Market by Application
6.4.1.1 LAMEA Epilepsy Market by Country
6.4.1.2 LAMEA Restless Legs Syndrome Market by Country
6.4.1.3 LAMEA Neuropathic Pain Market by Country
6.4.1.4 LAMEA Others Market by Country
6.4.2 LAMEA Gabapentin Market by Dosage Form
6.4.2.1 LAMEA Capsule Market by Country
6.4.2.2 LAMEA Tablet Market by Country
6.4.2.3 LAMEA Oral Solution Market by Country
6.4.3 LAMEA Gabapentin Market by Distribution Channel
6.4.3.1 LAMEA Hospital Pharmacy Market by Country
6.4.3.2 LAMEA Retail Pharmacy Market by Country
6.4.3.3 LAMEA Online Pharmacy Market by Country
6.4.4 LAMEA Gabapentin Market by Country
6.4.4.1 Brazil Gabapentin Market
6.4.4.1.1 Brazil Gabapentin Market by Application
6.4.4.1.2 Brazil Gabapentin Market by Dosage Form
6.4.4.1.3 Brazil Gabapentin Market by Distribution Channel
6.4.4.2 Argentina Gabapentin Market
6.4.4.2.1 Argentina Gabapentin Market by Application
6.4.4.2.2 Argentina Gabapentin Market by Dosage Form
6.4.4.2.3 Argentina Gabapentin Market by Distribution Channel
6.4.4.3 UAE Gabapentin Market
6.4.4.3.1 UAE Gabapentin Market by Application
6.4.4.3.2 UAE Gabapentin Market by Dosage Form
6.4.4.3.3 UAE Gabapentin Market by Distribution Channel
6.4.4.4 Saudi Arabia Gabapentin Market
6.4.4.4.1 Saudi Arabia Gabapentin Market by Application
6.4.4.4.2 Saudi Arabia Gabapentin Market by Dosage Form
6.4.4.4.3 Saudi Arabia Gabapentin Market by Distribution Channel
6.4.4.5 South Africa Gabapentin Market
6.4.4.5.1 South Africa Gabapentin Market by Application
6.4.4.5.2 South Africa Gabapentin Market by Dosage Form
6.4.4.5.3 South Africa Gabapentin Market by Distribution Channel
6.4.4.6 Nigeria Gabapentin Market
6.4.4.6.1 Nigeria Gabapentin Market by Application
6.4.4.6.2 Nigeria Gabapentin Market by Dosage Form
6.4.4.6.3 Nigeria Gabapentin Market by Distribution Channel
6.4.4.7 Rest of LAMEA Gabapentin Market
6.4.4.7.1 Rest of LAMEA Gabapentin Market by Application
6.4.4.7.2 Rest of LAMEA Gabapentin Market by Dosage Form
6.4.4.7.3 Rest of LAMEA Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gabapentin Market, by Application
1.4.2 Global Gabapentin Market, by Dosage Form
1.4.3 Global Gabapentin Market, by Distribution Channel
1.4.4 Global Gabapentin Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Gabapentin Market by Application
3.1 Global Epilepsy Market by Region
3.2 Global Restless Legs Syndrome Market by Region
3.3 Global Neuropathic Pain Market by Region
3.4 Global Others Market by Region
Chapter 4. Global Gabapentin Market by Dosage Form
4.1 Global Capsule Market by Region
4.2 Global Tablet Market by Region
4.3 Global Oral Solution Market by Region
Chapter 5. Global Gabapentin Market by Distribution Channel
5.1 Global Hospital Pharmacy Market by Region
5.2 Global Retail Pharmacy Market by Region
5.3 Global Online Pharmacy Market by Region
Chapter 6. Global Gabapentin Market by Region
6.1 North America Gabapentin Market
6.1.1 North America Gabapentin Market by Application
6.1.1.1 North America Epilepsy Market by Country
6.1.1.2 North America Restless Legs Syndrome Market by Country
6.1.1.3 North America Neuropathic Pain Market by Country
6.1.1.4 North America Others Market by Country
6.1.2 North America Gabapentin Market by Dosage Form
6.1.2.1 North America Capsule Market by Country
6.1.2.2 North America Tablet Market by Country
6.1.2.3 North America Oral Solution Market by Country
6.1.3 North America Gabapentin Market by Distribution Channel
6.1.3.1 North America Hospital Pharmacy Market by Country
6.1.3.2 North America Retail Pharmacy Market by Country
6.1.3.3 North America Online Pharmacy Market by Country
6.1.4 North America Gabapentin Market by Country
6.1.4.1 US Gabapentin Market
6.1.4.1.1 US Gabapentin Market by Application
6.1.4.1.2 US Gabapentin Market by Dosage Form
6.1.4.1.3 US Gabapentin Market by Distribution Channel
6.1.4.2 Canada Gabapentin Market
6.1.4.2.1 Canada Gabapentin Market by Application
6.1.4.2.2 Canada Gabapentin Market by Dosage Form
6.1.4.2.3 Canada Gabapentin Market by Distribution Channel
6.1.4.3 Mexico Gabapentin Market
6.1.4.3.1 Mexico Gabapentin Market by Application
6.1.4.3.2 Mexico Gabapentin Market by Dosage Form
6.1.4.3.3 Mexico Gabapentin Market by Distribution Channel
6.1.4.4 Rest of North America Gabapentin Market
6.1.4.4.1 Rest of North America Gabapentin Market by Application
6.1.4.4.2 Rest of North America Gabapentin Market by Dosage Form
6.1.4.4.3 Rest of North America Gabapentin Market by Distribution Channel
6.2 Europe Gabapentin Market
6.2.1 Europe Gabapentin Market by Application
6.2.1.1 Europe Epilepsy Market by Country
6.2.1.2 Europe Restless Legs Syndrome Market by Country
6.2.1.3 Europe Neuropathic Pain Market by Country
6.2.1.4 Europe Others Market by Country
6.2.2 Europe Gabapentin Market by Dosage Form
6.2.2.1 Europe Capsule Market by Country
6.2.2.2 Europe Tablet Market by Country
6.2.2.3 Europe Oral Solution Market by Country
6.2.3 Europe Gabapentin Market by Distribution Channel
6.2.3.1 Europe Hospital Pharmacy Market by Country
6.2.3.2 Europe Retail Pharmacy Market by Country
6.2.3.3 Europe Online Pharmacy Market by Country
6.2.4 Europe Gabapentin Market by Country
6.2.4.1 Germany Gabapentin Market
6.2.4.1.1 Germany Gabapentin Market by Application
6.2.4.1.2 Germany Gabapentin Market by Dosage Form
6.2.4.1.3 Germany Gabapentin Market by Distribution Channel
6.2.4.2 UK Gabapentin Market
6.2.4.2.1 UK Gabapentin Market by Application
6.2.4.2.2 UK Gabapentin Market by Dosage Form
6.2.4.2.3 UK Gabapentin Market by Distribution Channel
6.2.4.3 France Gabapentin Market
6.2.4.3.1 France Gabapentin Market by Application
6.2.4.3.2 France Gabapentin Market by Dosage Form
6.2.4.3.3 France Gabapentin Market by Distribution Channel
6.2.4.4 Russia Gabapentin Market
6.2.4.4.1 Russia Gabapentin Market by Application
6.2.4.4.2 Russia Gabapentin Market by Dosage Form
6.2.4.4.3 Russia Gabapentin Market by Distribution Channel
6.2.4.5 Spain Gabapentin Market
6.2.4.5.1 Spain Gabapentin Market by Application
6.2.4.5.2 Spain Gabapentin Market by Dosage Form
6.2.4.5.3 Spain Gabapentin Market by Distribution Channel
6.2.4.6 Italy Gabapentin Market
6.2.4.6.1 Italy Gabapentin Market by Application
6.2.4.6.2 Italy Gabapentin Market by Dosage Form
6.2.4.6.3 Italy Gabapentin Market by Distribution Channel
6.2.4.7 Rest of Europe Gabapentin Market
6.2.4.7.1 Rest of Europe Gabapentin Market by Application
6.2.4.7.2 Rest of Europe Gabapentin Market by Dosage Form
6.2.4.7.3 Rest of Europe Gabapentin Market by Distribution Channel
6.3 Asia Pacific Gabapentin Market
6.3.1 Asia Pacific Gabapentin Market by Application
6.3.1.1 Asia Pacific Epilepsy Market by Country
6.3.1.2 Asia Pacific Restless Legs Syndrome Market by Country
6.3.1.3 Asia Pacific Neuropathic Pain Market by Country
6.3.1.4 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Gabapentin Market by Dosage Form
6.3.2.1 Asia Pacific Capsule Market by Country
6.3.2.2 Asia Pacific Tablet Market by Country
6.3.2.3 Asia Pacific Oral Solution Market by Country
6.3.3 Asia Pacific Gabapentin Market by Distribution Channel
6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
6.3.3.3 Asia Pacific Online Pharmacy Market by Country
6.3.4 Asia Pacific Gabapentin Market by Country
6.3.4.1 China Gabapentin Market
6.3.4.1.1 China Gabapentin Market by Application
6.3.4.1.2 China Gabapentin Market by Dosage Form
6.3.4.1.3 China Gabapentin Market by Distribution Channel
6.3.4.2 Japan Gabapentin Market
6.3.4.2.1 Japan Gabapentin Market by Application
6.3.4.2.2 Japan Gabapentin Market by Dosage Form
6.3.4.2.3 Japan Gabapentin Market by Distribution Channel
6.3.4.3 India Gabapentin Market
6.3.4.3.1 India Gabapentin Market by Application
6.3.4.3.2 India Gabapentin Market by Dosage Form
6.3.4.3.3 India Gabapentin Market by Distribution Channel
6.3.4.4 South Korea Gabapentin Market
6.3.4.4.1 South Korea Gabapentin Market by Application
6.3.4.4.2 South Korea Gabapentin Market by Dosage Form
6.3.4.4.3 South Korea Gabapentin Market by Distribution Channel
6.3.4.5 Singapore Gabapentin Market
6.3.4.5.1 Singapore Gabapentin Market by Application
6.3.4.5.2 Singapore Gabapentin Market by Dosage Form
6.3.4.5.3 Singapore Gabapentin Market by Distribution Channel
6.3.4.6 Malaysia Gabapentin Market
6.3.4.6.1 Malaysia Gabapentin Market by Application
6.3.4.6.2 Malaysia Gabapentin Market by Dosage Form
6.3.4.6.3 Malaysia Gabapentin Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Gabapentin Market
6.3.4.7.1 Rest of Asia Pacific Gabapentin Market by Application
6.3.4.7.2 Rest of Asia Pacific Gabapentin Market by Dosage Form
6.3.4.7.3 Rest of Asia Pacific Gabapentin Market by Distribution Channel
6.4 LAMEA Gabapentin Market
6.4.1 LAMEA Gabapentin Market by Application
6.4.1.1 LAMEA Epilepsy Market by Country
6.4.1.2 LAMEA Restless Legs Syndrome Market by Country
6.4.1.3 LAMEA Neuropathic Pain Market by Country
6.4.1.4 LAMEA Others Market by Country
6.4.2 LAMEA Gabapentin Market by Dosage Form
6.4.2.1 LAMEA Capsule Market by Country
6.4.2.2 LAMEA Tablet Market by Country
6.4.2.3 LAMEA Oral Solution Market by Country
6.4.3 LAMEA Gabapentin Market by Distribution Channel
6.4.3.1 LAMEA Hospital Pharmacy Market by Country
6.4.3.2 LAMEA Retail Pharmacy Market by Country
6.4.3.3 LAMEA Online Pharmacy Market by Country
6.4.4 LAMEA Gabapentin Market by Country
6.4.4.1 Brazil Gabapentin Market
6.4.4.1.1 Brazil Gabapentin Market by Application
6.4.4.1.2 Brazil Gabapentin Market by Dosage Form
6.4.4.1.3 Brazil Gabapentin Market by Distribution Channel
6.4.4.2 Argentina Gabapentin Market
6.4.4.2.1 Argentina Gabapentin Market by Application
6.4.4.2.2 Argentina Gabapentin Market by Dosage Form
6.4.4.2.3 Argentina Gabapentin Market by Distribution Channel
6.4.4.3 UAE Gabapentin Market
6.4.4.3.1 UAE Gabapentin Market by Application
6.4.4.3.2 UAE Gabapentin Market by Dosage Form
6.4.4.3.3 UAE Gabapentin Market by Distribution Channel
6.4.4.4 Saudi Arabia Gabapentin Market
6.4.4.4.1 Saudi Arabia Gabapentin Market by Application
6.4.4.4.2 Saudi Arabia Gabapentin Market by Dosage Form
6.4.4.4.3 Saudi Arabia Gabapentin Market by Distribution Channel
6.4.4.5 South Africa Gabapentin Market
6.4.4.5.1 South Africa Gabapentin Market by Application
6.4.4.5.2 South Africa Gabapentin Market by Dosage Form
6.4.4.5.3 South Africa Gabapentin Market by Distribution Channel
6.4.4.6 Nigeria Gabapentin Market
6.4.4.6.1 Nigeria Gabapentin Market by Application
6.4.4.6.2 Nigeria Gabapentin Market by Dosage Form
6.4.4.6.3 Nigeria Gabapentin Market by Distribution Channel
6.4.4.7 Rest of LAMEA Gabapentin Market
6.4.4.7.1 Rest of LAMEA Gabapentin Market by Application
6.4.4.7.2 Rest of LAMEA Gabapentin Market by Dosage Form
6.4.4.7.3 Rest of LAMEA Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
List of Tables
TABLE 1 Global Gabapentin Market, 2018 - 2021, USD Million
TABLE 2 Global Gabapentin Market, 2022 - 2028, USD Million
TABLE 3 Global Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 4 Global Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 5 Global Epilepsy Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Epilepsy Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Restless Legs Syndrome Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Restless Legs Syndrome Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Neuropathic Pain Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Neuropathic Pain Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 14 Global Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 15 Global Capsule Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Capsule Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Tablet Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Tablet Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Oral Solution Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Oral Solution Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 22 Global Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 23 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Gabapentin Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Gabapentin Market by Region, 2022 - 2028, USD Million
TABLE 31 North America Gabapentin Market, 2018 - 2021, USD Million
TABLE 32 North America Gabapentin Market, 2022 - 2028, USD Million
TABLE 33 North America Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 34 North America Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 35 North America Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 44 North America Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 45 North America Capsule Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Capsule Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Tablet Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Tablet Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 North America Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 61 US Gabapentin Market, 2018 - 2021, USD Million
TABLE 62 US Gabapentin Market, 2022 - 2028, USD Million
TABLE 63 US Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 64 US Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 65 US Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 66 US Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 67 US Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 US Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Canada Gabapentin Market, 2018 - 2021, USD Million
TABLE 70 Canada Gabapentin Market, 2022 - 2028, USD Million
TABLE 71 Canada Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 72 Canada Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 73 Canada Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 74 Canada Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 75 Canada Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Canada Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Mexico Gabapentin Market, 2018 - 2021, USD Million
TABLE 78 Mexico Gabapentin Market, 2022 - 2028, USD Million
TABLE 79 Mexico Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 80 Mexico Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 81 Mexico Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 82 Mexico Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 83 Mexico Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Mexico Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Rest of North America Gabapentin Market, 2018 - 2021, USD Million
TABLE 86 Rest of North America Gabapentin Market, 2022 - 2028, USD Million
TABLE 87 Rest of North America Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 88 Rest of North America Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 89 Rest of North America Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 90 Rest of North America Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 91 Rest of North America Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 92 Rest of North America Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 93 Europe Gabapentin Market, 2018 - 2021, USD Million
TABLE 94 Europe Gabapentin Market, 2022 - 2028, USD Million
TABLE 95 Europe Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 96 Europe Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 97 Europe Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 100 Europe Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 101 Europe Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 105 Europe Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 106 Europe Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 107 Europe Capsule Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Capsule Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Tablet Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Tablet Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 114 Europe Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 115 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 123 Germany Gabapentin Market, 2018 - 2021, USD Million
TABLE 124 Germany Gabapentin Market, 2022 - 2028, USD Million
TABLE 125 Germany Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 126 Germany Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 127 Germany Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 128 Germany Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 129 Germany Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 130 Germany Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 131 UK Gabapentin Market, 2018 - 2021, USD Million
TABLE 132 UK Gabapentin Market, 2022 - 2028, USD Million
TABLE 133 UK Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 134 UK Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 135 UK Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 136 UK Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 137 UK Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 138 UK Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 139 France Gabapentin Market, 2018 - 2021, USD Million
TABLE 140 France Gabapentin Market, 2022 - 2028, USD Million
TABLE 141 France Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 142 France Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 143 France Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 144 France Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 145 France Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 146 France Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 147 Russia Gabapentin Market, 2018 - 2021, USD Million
TABLE 148 Russia Gabapentin Market, 2022 - 2028, USD Million
TABLE 149 Russia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 150 Russia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 151 Russia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 152 Russia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 153 Russia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 154 Russia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 155 Spain Gabapentin Market, 2018 - 2021, USD Million
TABLE 156 Spain Gabapentin Market, 2022 - 2028, USD Million
TABLE 157 Spain Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 158 Spain Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 159 Spain Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 160 Spain Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 161 Spain Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 162 Spain Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 163 Italy Gabapentin Market, 2018 - 2021, USD Million
TABLE 164 Italy Gabapentin Market, 2022 - 2028, USD Million
TABLE 165 Italy Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 166 Italy Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 167 Italy Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 168 Italy Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 169 Italy Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 170 Italy Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 171 Rest of Europe Gabapentin Market, 2018 - 2021, USD Million
TABLE 172 Rest of Europe Gabapentin Market, 2022 - 2028, USD Million
TABLE 173 Rest of Europe Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 174 Rest of Europe Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 175 Rest of Europe Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 176 Rest of Europe Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 177 Rest of Europe Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 178 Rest of Europe Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Gabapentin Market, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Gabapentin Market, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Capsule Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Capsule Market by Country, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Tablet Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Tablet Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 209 China Gabapentin Market, 2018 - 2021, USD Million
TABLE 210 China Gabapentin Market, 2022 - 2028, USD Million
TABLE 211 China Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 212 China Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 213 China Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 214 China Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 215 China Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 216 China Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 217 Japan Gabapentin Market, 2018 - 2021, USD Million
TABLE 218 Japan Gabapentin Market, 2022 - 2028, USD Million
TABLE 219 Japan Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 220 Japan Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 221 Japan Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 222 Japan Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 223 Japan Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 224 Japan Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 225 India Gabapentin Market, 2018 - 2021, USD Million
TABLE 226 India Gabapentin Market, 2022 - 2028, USD Million
TABLE 227 India Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 228 India Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 229 India Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 230 India Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 231 India Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 232 India Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 233 South Korea Gabapentin Market, 2018 - 2021, USD Million
TABLE 234 South Korea Gabapentin Market, 2022 - 2028, USD Million
TABLE 235 South Korea Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 236 South Korea Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 237 South Korea Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 238 South Korea Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 239 South Korea Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 240 South Korea Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 241 Singapore Gabapentin Market, 2018 - 2021, USD Million
TABLE 242 Singapore Gabapentin Market, 2022 - 2028, USD Million
TABLE 243 Singapore Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 244 Singapore Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 245 Singapore Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 246 Singapore Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 247 Singapore Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 248 Singapore Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 249 Malaysia Gabapentin Market, 2018 - 2021, USD Million
TABLE 250 Malaysia Gabapentin Market, 2022 - 2028, USD Million
TABLE 251 Malaysia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 252 Malaysia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 253 Malaysia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 254 Malaysia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 255 Malaysia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 256 Malaysia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 257 Rest of Asia Pacific Gabapentin Market, 2018 - 2021, USD Million
TABLE 258 Rest of Asia Pacific Gabapentin Market, 2022 - 2028, USD Million
TABLE 259 Rest of Asia Pacific Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 260 Rest of Asia Pacific Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 261 Rest of Asia Pacific Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 262 Rest of Asia Pacific Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 263 Rest of Asia Pacific Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 264 Rest of Asia Pacific Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 265 LAMEA Gabapentin Market, 2018 - 2021, USD Million
TABLE 266 LAMEA Gabapentin Market, 2022 - 2028, USD Million
TABLE 267 LAMEA Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 268 LAMEA Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 269 LAMEA Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 270 LAMEA Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 271 LAMEA Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 272 LAMEA Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 273 LAMEA Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 274 LAMEA Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 275 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 276 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 277 LAMEA Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 278 LAMEA Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 279 LAMEA Capsule Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Capsule Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Tablet Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Tablet Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 284 LAMEA Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 285 LAMEA Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 286 LAMEA Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 287 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 292 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 293 LAMEA Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 295 Brazil Gabapentin Market, 2018 - 2021, USD Million
TABLE 296 Brazil Gabapentin Market, 2022 - 2028, USD Million
TABLE 297 Brazil Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 298 Brazil Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 299 Brazil Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 300 Brazil Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 301 Brazil Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 302 Brazil Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 303 Argentina Gabapentin Market, 2018 - 2021, USD Million
TABLE 304 Argentina Gabapentin Market, 2022 - 2028, USD Million
TABLE 305 Argentina Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 306 Argentina Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 307 Argentina Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 308 Argentina Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 309 Argentina Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 310 Argentina Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 311 UAE Gabapentin Market, 2018 - 2021, USD Million
TABLE 312 UAE Gabapentin Market, 2022 - 2028, USD Million
TABLE 313 UAE Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 314 UAE Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 315 UAE Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 316 UAE Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 317 UAE Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 318 UAE Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 319 Saudi Arabia Gabapentin Market, 2018 - 2021, USD Million
TABLE 320 Saudi Arabia Gabapentin Market, 2022 - 2028, USD Million
TABLE 321 Saudi Arabia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 322 Saudi Arabia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 323 Saudi Arabia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 324 Saudi Arabia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 325 Saudi Arabia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 326 Saudi Arabia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 327 South Africa Gabapentin Market, 2018 - 2021, USD Million
TABLE 328 South Africa Gabapentin Market, 2022 - 2028, USD Million
TABLE 329 South Africa Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 330 South Africa Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 331 South Africa Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 332 South Africa Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 333 South Africa Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 334 South Africa Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 335 Nigeria Gabapentin Market, 2018 - 2021, USD Million
TABLE 336 Nigeria Gabapentin Market, 2022 - 2028, USD Million
TABLE 337 Nigeria Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 338 Nigeria Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 339 Nigeria Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 340 Nigeria Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 341 Nigeria Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 342 Nigeria Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 343 Rest of LAMEA Gabapentin Market, 2018 - 2021, USD Million
TABLE 344 Rest of LAMEA Gabapentin Market, 2022 - 2028, USD Million
TABLE 345 Rest of LAMEA Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 346 Rest of LAMEA Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 347 Rest of LAMEA Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 348 Rest of LAMEA Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 349 Rest of LAMEA Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 350 Rest of LAMEA Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 351 Key Information – Zydus Lifesciences Ltd.
TABLE 352 Key Information – Glenmark Pharmaceuticals Limited
TABLE 353 Key Information – Pfizer, Inc.
TABLE 354 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 355 Key Information – Alkem Laboratories Ltd.
TABLE 356 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 357 key information – Aurobindo Pharma Limited
TABLE 358 Key Information – Amneal Pharmaceuticals, INc.
TABLE 359 Key Information – Cipla Limited
TABLE 360 Key Information – Apotex, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Gabapentin Market share by Application, 2021
FIG 3 Global Gabapentin Market share by Application, 2028
FIG 4 Global Gabapentin Market by Application, 2018 - 2028, USD Million
FIG 5 Global Gabapentin Market share by Dosage Form, 2021
FIG 6 Global Gabapentin Market share by Dosage Form, 2028
FIG 7 Global Gabapentin Market by Dosage Form, 2018 - 2028, USD Million
FIG 8 Global Gabapentin Market share by Distribution Channel, 2021
FIG 9 Global Gabapentin Market share by Distribution Channel, 2028
FIG 10 Global Gabapentin Market by Distribution Channel, 2018 - 2028, USD Million
FIG 11 Global Gabapentin Market share by Region, 2021
FIG 12 Global Gabapentin Market share by Region, 2028
FIG 13 Global Gabapentin Market by Region, 2018 - 2028, USD Million
TABLE 2 Global Gabapentin Market, 2022 - 2028, USD Million
TABLE 3 Global Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 4 Global Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 5 Global Epilepsy Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Epilepsy Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Restless Legs Syndrome Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Restless Legs Syndrome Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Neuropathic Pain Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Neuropathic Pain Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 14 Global Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 15 Global Capsule Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Capsule Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Tablet Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Tablet Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Oral Solution Market by Region, 2018 - 2021, USD Million
TABLE 20 Global Oral Solution Market by Region, 2022 - 2028, USD Million
TABLE 21 Global Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 22 Global Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 23 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Gabapentin Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Gabapentin Market by Region, 2022 - 2028, USD Million
TABLE 31 North America Gabapentin Market, 2018 - 2021, USD Million
TABLE 32 North America Gabapentin Market, 2022 - 2028, USD Million
TABLE 33 North America Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 34 North America Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 35 North America Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 44 North America Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 45 North America Capsule Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Capsule Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Tablet Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Tablet Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 North America Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 61 US Gabapentin Market, 2018 - 2021, USD Million
TABLE 62 US Gabapentin Market, 2022 - 2028, USD Million
TABLE 63 US Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 64 US Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 65 US Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 66 US Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 67 US Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 US Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Canada Gabapentin Market, 2018 - 2021, USD Million
TABLE 70 Canada Gabapentin Market, 2022 - 2028, USD Million
TABLE 71 Canada Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 72 Canada Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 73 Canada Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 74 Canada Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 75 Canada Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Canada Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Mexico Gabapentin Market, 2018 - 2021, USD Million
TABLE 78 Mexico Gabapentin Market, 2022 - 2028, USD Million
TABLE 79 Mexico Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 80 Mexico Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 81 Mexico Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 82 Mexico Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 83 Mexico Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Mexico Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Rest of North America Gabapentin Market, 2018 - 2021, USD Million
TABLE 86 Rest of North America Gabapentin Market, 2022 - 2028, USD Million
TABLE 87 Rest of North America Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 88 Rest of North America Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 89 Rest of North America Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 90 Rest of North America Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 91 Rest of North America Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 92 Rest of North America Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 93 Europe Gabapentin Market, 2018 - 2021, USD Million
TABLE 94 Europe Gabapentin Market, 2022 - 2028, USD Million
TABLE 95 Europe Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 96 Europe Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 97 Europe Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 100 Europe Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 101 Europe Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 105 Europe Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 106 Europe Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 107 Europe Capsule Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Capsule Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Tablet Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Tablet Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 114 Europe Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 115 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 123 Germany Gabapentin Market, 2018 - 2021, USD Million
TABLE 124 Germany Gabapentin Market, 2022 - 2028, USD Million
TABLE 125 Germany Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 126 Germany Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 127 Germany Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 128 Germany Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 129 Germany Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 130 Germany Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 131 UK Gabapentin Market, 2018 - 2021, USD Million
TABLE 132 UK Gabapentin Market, 2022 - 2028, USD Million
TABLE 133 UK Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 134 UK Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 135 UK Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 136 UK Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 137 UK Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 138 UK Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 139 France Gabapentin Market, 2018 - 2021, USD Million
TABLE 140 France Gabapentin Market, 2022 - 2028, USD Million
TABLE 141 France Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 142 France Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 143 France Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 144 France Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 145 France Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 146 France Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 147 Russia Gabapentin Market, 2018 - 2021, USD Million
TABLE 148 Russia Gabapentin Market, 2022 - 2028, USD Million
TABLE 149 Russia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 150 Russia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 151 Russia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 152 Russia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 153 Russia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 154 Russia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 155 Spain Gabapentin Market, 2018 - 2021, USD Million
TABLE 156 Spain Gabapentin Market, 2022 - 2028, USD Million
TABLE 157 Spain Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 158 Spain Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 159 Spain Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 160 Spain Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 161 Spain Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 162 Spain Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 163 Italy Gabapentin Market, 2018 - 2021, USD Million
TABLE 164 Italy Gabapentin Market, 2022 - 2028, USD Million
TABLE 165 Italy Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 166 Italy Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 167 Italy Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 168 Italy Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 169 Italy Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 170 Italy Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 171 Rest of Europe Gabapentin Market, 2018 - 2021, USD Million
TABLE 172 Rest of Europe Gabapentin Market, 2022 - 2028, USD Million
TABLE 173 Rest of Europe Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 174 Rest of Europe Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 175 Rest of Europe Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 176 Rest of Europe Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 177 Rest of Europe Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 178 Rest of Europe Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Gabapentin Market, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Gabapentin Market, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Capsule Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Capsule Market by Country, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Tablet Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Tablet Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 209 China Gabapentin Market, 2018 - 2021, USD Million
TABLE 210 China Gabapentin Market, 2022 - 2028, USD Million
TABLE 211 China Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 212 China Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 213 China Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 214 China Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 215 China Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 216 China Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 217 Japan Gabapentin Market, 2018 - 2021, USD Million
TABLE 218 Japan Gabapentin Market, 2022 - 2028, USD Million
TABLE 219 Japan Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 220 Japan Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 221 Japan Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 222 Japan Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 223 Japan Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 224 Japan Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 225 India Gabapentin Market, 2018 - 2021, USD Million
TABLE 226 India Gabapentin Market, 2022 - 2028, USD Million
TABLE 227 India Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 228 India Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 229 India Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 230 India Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 231 India Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 232 India Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 233 South Korea Gabapentin Market, 2018 - 2021, USD Million
TABLE 234 South Korea Gabapentin Market, 2022 - 2028, USD Million
TABLE 235 South Korea Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 236 South Korea Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 237 South Korea Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 238 South Korea Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 239 South Korea Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 240 South Korea Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 241 Singapore Gabapentin Market, 2018 - 2021, USD Million
TABLE 242 Singapore Gabapentin Market, 2022 - 2028, USD Million
TABLE 243 Singapore Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 244 Singapore Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 245 Singapore Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 246 Singapore Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 247 Singapore Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 248 Singapore Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 249 Malaysia Gabapentin Market, 2018 - 2021, USD Million
TABLE 250 Malaysia Gabapentin Market, 2022 - 2028, USD Million
TABLE 251 Malaysia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 252 Malaysia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 253 Malaysia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 254 Malaysia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 255 Malaysia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 256 Malaysia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 257 Rest of Asia Pacific Gabapentin Market, 2018 - 2021, USD Million
TABLE 258 Rest of Asia Pacific Gabapentin Market, 2022 - 2028, USD Million
TABLE 259 Rest of Asia Pacific Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 260 Rest of Asia Pacific Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 261 Rest of Asia Pacific Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 262 Rest of Asia Pacific Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 263 Rest of Asia Pacific Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 264 Rest of Asia Pacific Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 265 LAMEA Gabapentin Market, 2018 - 2021, USD Million
TABLE 266 LAMEA Gabapentin Market, 2022 - 2028, USD Million
TABLE 267 LAMEA Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 268 LAMEA Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 269 LAMEA Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 270 LAMEA Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 271 LAMEA Restless Legs Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 272 LAMEA Restless Legs Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 273 LAMEA Neuropathic Pain Market by Country, 2018 - 2021, USD Million
TABLE 274 LAMEA Neuropathic Pain Market by Country, 2022 - 2028, USD Million
TABLE 275 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 276 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 277 LAMEA Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 278 LAMEA Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 279 LAMEA Capsule Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Capsule Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Tablet Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Tablet Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Oral Solution Market by Country, 2018 - 2021, USD Million
TABLE 284 LAMEA Oral Solution Market by Country, 2022 - 2028, USD Million
TABLE 285 LAMEA Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 286 LAMEA Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 287 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 292 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 293 LAMEA Gabapentin Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Gabapentin Market by Country, 2022 - 2028, USD Million
TABLE 295 Brazil Gabapentin Market, 2018 - 2021, USD Million
TABLE 296 Brazil Gabapentin Market, 2022 - 2028, USD Million
TABLE 297 Brazil Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 298 Brazil Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 299 Brazil Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 300 Brazil Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 301 Brazil Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 302 Brazil Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 303 Argentina Gabapentin Market, 2018 - 2021, USD Million
TABLE 304 Argentina Gabapentin Market, 2022 - 2028, USD Million
TABLE 305 Argentina Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 306 Argentina Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 307 Argentina Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 308 Argentina Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 309 Argentina Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 310 Argentina Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 311 UAE Gabapentin Market, 2018 - 2021, USD Million
TABLE 312 UAE Gabapentin Market, 2022 - 2028, USD Million
TABLE 313 UAE Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 314 UAE Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 315 UAE Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 316 UAE Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 317 UAE Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 318 UAE Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 319 Saudi Arabia Gabapentin Market, 2018 - 2021, USD Million
TABLE 320 Saudi Arabia Gabapentin Market, 2022 - 2028, USD Million
TABLE 321 Saudi Arabia Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 322 Saudi Arabia Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 323 Saudi Arabia Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 324 Saudi Arabia Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 325 Saudi Arabia Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 326 Saudi Arabia Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 327 South Africa Gabapentin Market, 2018 - 2021, USD Million
TABLE 328 South Africa Gabapentin Market, 2022 - 2028, USD Million
TABLE 329 South Africa Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 330 South Africa Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 331 South Africa Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 332 South Africa Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 333 South Africa Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 334 South Africa Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 335 Nigeria Gabapentin Market, 2018 - 2021, USD Million
TABLE 336 Nigeria Gabapentin Market, 2022 - 2028, USD Million
TABLE 337 Nigeria Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 338 Nigeria Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 339 Nigeria Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 340 Nigeria Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 341 Nigeria Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 342 Nigeria Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 343 Rest of LAMEA Gabapentin Market, 2018 - 2021, USD Million
TABLE 344 Rest of LAMEA Gabapentin Market, 2022 - 2028, USD Million
TABLE 345 Rest of LAMEA Gabapentin Market by Application, 2018 - 2021, USD Million
TABLE 346 Rest of LAMEA Gabapentin Market by Application, 2022 - 2028, USD Million
TABLE 347 Rest of LAMEA Gabapentin Market by Dosage Form, 2018 - 2021, USD Million
TABLE 348 Rest of LAMEA Gabapentin Market by Dosage Form, 2022 - 2028, USD Million
TABLE 349 Rest of LAMEA Gabapentin Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 350 Rest of LAMEA Gabapentin Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 351 Key Information – Zydus Lifesciences Ltd.
TABLE 352 Key Information – Glenmark Pharmaceuticals Limited
TABLE 353 Key Information – Pfizer, Inc.
TABLE 354 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 355 Key Information – Alkem Laboratories Ltd.
TABLE 356 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 357 key information – Aurobindo Pharma Limited
TABLE 358 Key Information – Amneal Pharmaceuticals, INc.
TABLE 359 Key Information – Cipla Limited
TABLE 360 Key Information – Apotex, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Global Gabapentin Market share by Application, 2021
FIG 3 Global Gabapentin Market share by Application, 2028
FIG 4 Global Gabapentin Market by Application, 2018 - 2028, USD Million
FIG 5 Global Gabapentin Market share by Dosage Form, 2021
FIG 6 Global Gabapentin Market share by Dosage Form, 2028
FIG 7 Global Gabapentin Market by Dosage Form, 2018 - 2028, USD Million
FIG 8 Global Gabapentin Market share by Distribution Channel, 2021
FIG 9 Global Gabapentin Market share by Distribution Channel, 2028
FIG 10 Global Gabapentin Market by Distribution Channel, 2018 - 2028, USD Million
FIG 11 Global Gabapentin Market share by Region, 2021
FIG 12 Global Gabapentin Market share by Region, 2028
FIG 13 Global Gabapentin Market by Region, 2018 - 2028, USD Million